Literature DB >> 28214100

NLRP6: A Multifaceted Innate Immune Sensor.

Maayan Levy1, Hagit Shapiro1, Christoph A Thaiss1, Eran Elinav2.   

Abstract

NLRP6, a member of the nucleotide-binding domain, leucine-rich repeat-containing (NLR) innate immune receptor family, regulates inflammation and host defense against microorganisms. Similar to other NLRs, NLRP6 not only participates in inflammasome formation, but is also involved in nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling regulation and facilitation of gastrointestinal antiviral effector functions. Additionally, NLRP6 contributes to the regulation of mucus secretion and antimicrobial peptide production, thereby impacting intestinal microbial colonization and associated microbiome-related infectious, autoinflammatory, metabolic, and neoplastic diseases. However, several of the mechanisms attributed to the functions of NLRP6 remain debatable, leaving open questions as to the relevant molecular mechanisms and interacting partners, and putative human relevance. We herein discuss recent findings related to NLRP6 activity, while highlighting outstanding questions and future perspectives in elucidating its roles in health and disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28214100     DOI: 10.1016/j.it.2017.01.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  35 in total

1.  Effects of NLRP6 in Cerebral Ischemia/Reperfusion (I/R) Injury in Rats.

Authors:  Changchang Meng; Jinyan Zhang; Luyu Zhang; Yueting Wang; Zhenyu Li; Jing Zhao
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

Review 2.  The NLRP6 inflammasome in health and disease.

Authors:  Laxman Ghimire; Sagar Paudel; Liliang Jin; Samithamby Jeyaseelan
Journal:  Mucosal Immunol       Date:  2020-01-27       Impact factor: 7.313

3.  Molecular mechanism for NLRP6 inflammasome assembly and activation.

Authors:  Chen Shen; Alvin Lu; Wen Jun Xie; Jianbin Ruan; Roberto Negro; Edward H Egelman; Tian-Min Fu; Hao Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-23       Impact factor: 11.205

4.  Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.

Authors:  Chen-Tian Shen; Guo-Qiang Zhang; Zhong-Ling Qiu; Hong-Jun Song; Zhen-Kui Sun; Quan-Yong Luo
Journal:  Endocrine       Date:  2019-03-02       Impact factor: 3.633

Review 5.  The gut microbiota: a double-edged sword in endometriosis†.

Authors:  Chandni Talwar; Vertika Singh; Ramakrishna Kommagani
Journal:  Biol Reprod       Date:  2022-10-11       Impact factor: 4.161

Review 6.  Inflammasome activation: from molecular mechanisms to autoinflammation.

Authors:  Samuel Lara-Reyna; Emily A Caseley; Joanne Topping; François Rodrigues; Jorge Jimenez Macias; Sean E Lawler; Michael F McDermott
Journal:  Clin Transl Immunology       Date:  2022-07-07

Review 7.  Inflammasomes and the fine line between defense and disease.

Authors:  Shelbi Christgen; Thirumala-Devi Kanneganti
Journal:  Curr Opin Immunol       Date:  2019-12-25       Impact factor: 7.486

8.  The Influence of Bifidobacterium bifidum and Bacteroides fragilis on Enteric Glial Cell-Derived Neurotrophic Factors and Inflammasome.

Authors:  Peng-Chun Yang; Xi-Jun Li; Yan-Hua Yang; Wei Qian; Shi-Yu Li; Cai-Hua Yan; Jing Wang; Qin Wang; Xiao-Hua Hou; Chi-Bing Dai
Journal:  Inflammation       Date:  2020-12       Impact factor: 4.092

Review 9.  Therapeutic implications of inflammasome in inflammatory bowel disease.

Authors:  Vishal Khatri; Ramaswamy Kalyanasundaram
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

Review 10.  Inflammasomes and Fibrosis.

Authors:  Wen-Juan Zhang; Shu-Juan Chen; Shun-Chang Zhou; Su-Zhen Wu; Hui Wang
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.